Stock Market Reviews

Read and share opinions on TWST (Twist Bioscience Corporation) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock ma

Latest News

• Biotech Beat Nvidia in 2025. Can It Do It Again?
  Big pharma and biotech take the earnings stage with reports from Eli Lilly and Novo Nordisk leading the lineup. Will they help the industry once again outperform AI champ Nvidia?
  Feb 11, 2026
• Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes
  SOUTH SAN FRANCISCO, Calif., February 10, 2026--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched the Twist TrueAmp Library Preparation Kit and Twist PCR-Free WGS Library Preparation Kit, each designed to address a wide range of sample input, including low input and challenging sample types, to enable clinical research.
  Feb 10, 2026
• Twist Bioscience Annual Meeting: Shareholders Elect Directors, Approve Pay and EY Auditor Ratification
  Twist Bioscience (NASDAQ:TWST) held its 2026 annual meeting of stockholders via an online webcast, with Lead Independent Director Robert Chess serving as chairman. The meeting focused on three standard items of corporate governance: electing directors, conducting a non-binding advisory vote on execu
  Feb 9, 2026
• Twist Bioscience Guidance Lift Puts AI Demand And Risks In Focus
  Twist Bioscience (NasdaqGS:TWST) raised its full year revenue guidance, reflecting updated expectations for its business in synthetic DNA and protein solutions. The company highlighted strong demand for its AI enabled DNA and protein platforms, supported by expanding collaborations across discovery and research. Twist Bioscience also announced significant inducement equity awards tied to recent hires, aimed at supporting ongoing growth initiatives. Twist Bioscience, trading at $48.12, has...
  Feb 5, 2026
• Assessing Twist Bioscience (TWST) Valuation After Recent Share Price Momentum
  What recent performance says about Twist Bioscience (TWST) Twist Bioscience (TWST) has attracted fresh attention after a sharp move in its share price, with the stock showing double digit gains over the past month and over the past three months. At a last close of US$46.32, the company now has a three-year total return of 76.9%, alongside a 12-month total return of an 11% decline and a five-year total return of a 74.2% decline. See our latest analysis for Twist Bioscience. The recent 43%...
  Feb 4, 2026
• Twist Bioscience Corporation (TWST): A Bull Case Theory
  We came across a bullish thesis on Twist Bioscience Corporation on Clinical Catalysts’s Substack. In this article, we will summarize the bulls’ thesis on TWST. Twist Bioscience Corporation’s share was trading at $41.58 as of January 29th. Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. TWST has built a differentiated position through its silicon-based DNA synthesis technology, which enables […]
  Feb 3, 2026
• Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
  SOUTH SAN FRANCISCO, Calif., February 03, 2026--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) ("Twist" or the "Company"), a mid-cap growth and value biotech company, today announced that a total of 114,869 equity awards, consisting of 107,742 restricted stock units ("RSUs") and up to 7,127 performance stock units ("PSUs"), will be granted to 52 recently hired individuals, in each case as an inducement material to their acceptance of employment w
  Feb 3, 2026
• Twist Bioscience Q1 Earnings Call Highlights
  Twist Bioscience (NASDAQ:TWST) reported fiscal 2026 first-quarter results that management said extended a multi-year trend of consistent execution, highlighting its 12th consecutive quarter of revenue growth and continued progress toward profitability. On the company’s earnings call, executives emph
  Feb 2, 2026
• Twist Bioscience Q1 2026 Earnings Call Transcript
  With me on the call today are Dr. Emily Leproust, CEO and co-founder of Twist Bioscience Corporation, Adam Laponis, CFO of Twist Bioscience Corporation, and Dr. Patrick Finn, President and COO of Twist Bioscience Corporation. Today, we will discuss our business progress, financial and operational performance, as well as growth opportunities.
  Feb 2, 2026
• Twist Bioscience (TWST) Reports Q1 Loss, Misses Revenue Estimates
  Twist Bioscience (TWST) delivered earnings and revenue surprises of -5.26% and -0.05%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
  Feb 2, 2026
• Twist Bioscience: Fiscal Q1 Earnings Snapshot
  TWST) on Monday reported a loss of $30.5 million in its fiscal first quarter. On a per-share basis, the South San Francisco, California-based company said it had a loss of 50 cents. The maker of synthetic DNA for the biotechnology industry posted revenue of $103.7 million in the period.
  Feb 2, 2026
• Twist Bioscience Corp (TWST) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...
  Twist Bioscience Corp (TWST) reports a 17% revenue increase, driven by AI-enabled discovery and strategic investments, while aiming for EBITDA breakeven by fiscal year-end.
  Feb 2, 2026
• Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results
  SOUTH SAN FRANCISCO, Calif., February 02, 2026--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the first quarter fiscal 2026 ended December 31, 2025.
  Feb 2, 2026
• Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for
  Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  Jan 27, 2026
• Will Twist Bioscience (TWST) Report Negative Earnings Next Week? What You Should Know
  Twist Bioscience (TWST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  Jan 26, 2026
• Antibody Discovery Market to Hit USD 35.35 Billion by 2035, Driven by AI and Technology Innovations
  The global antibody discovery market, valued at USD 11.15 billion in 2025, is expected to surge to USD 35.35 billion by 2035, growing at a CAGR of 12.23%. This growth is fueled by advancements in engineering technologies, automation, and AI, benefiting the development of fully human and humanized antibodies, which enhance therapeutic attributes. Major technologies like phage display and glycoengineering propel this trend. AI and machine learning are streamlining discovery, while innovations such
  Jan 22, 2026
• Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue
  SOUTH SAN FRANCISCO, Calif., January 12, 2026--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced preliminary, unaudited revenue for the first quarter of fiscal 2026 ended December 31, 2025.
  Jan 12, 2026
• Twist Bioscience (TWST) Valuation Check After TD Cowen Buy Rating And Raised Outlook
  Twist Bioscience (TWST) is back on investor watchlists after TD Cowen’s Brendan Smith reaffirmed his positive stance on the company and significantly raised his outlook, accompanied by broadly supportive views from other brokers. See our latest analysis for Twist Bioscience. At a share price of $35.32, Twist Bioscience has seen short term momentum pick up, with a 90 day share price return of 13.24%. Over the same period, the 1 year total shareholder return shows an 18.99% decline, while the 3...
  Jan 11, 2026
• Cathie Wood Doubles Down on Biotech as 2025 Ends, Offloads Rocket Lab
  Cathie Wood Makes Late-Year Biotech Push, Dials Down Growth Names
  Dec 31, 2025
• Barclays Keeps Its Overweight Rating On Twist Bioscience Corporation (TWST)
  Twist Bioscience Corporation (NASDAQ:TWST) is among the 12 Best Genomics Stocks to Invest In. TheFly reported on December 15, 2025, that Barclays kept its Overweight rating and boosted its price objective for Twist Bioscience Corporation (NASDAQ:TWST) from $37 to $39. The move was included in the company’s more comprehensive 2026 outlook report for the life […]
  Dec 31, 2025

• FinTechFrost

  Feb 14, 2026

  $TWST This stock is like that amazing science project you actually understand—except it turns out the results might be a bit unpredictable!

  Buy

• BearFighter

  Feb 14, 2026

  $TWST Just another biotech legend in its own mind.

  Sell

• FinTechFrost

  Feb 14, 2026

  $TWST Turning DNA into data like they’re playing a video game! I just hope they don’t unlock the ‘zombie virus’ level.

  Buy

• BullRunBoss

  Feb 14, 2026

  $TWST This stock is brewing science like a mad scientist! If only their experiments included teleportation, we’d all be way ahead!

  Buy

• TheFiscalShade

  Feb 13, 2026

  $TWST Mixing science and swagger, these innovators are on fire!

  Buy

• ShortSurge

  Feb 12, 2026

  $TWST In the rapidly evolving biotech landscape, this organization is making strides with its innovative approaches to life sciences. Their focus on technological advancements and research positions them well for future growth.

  Buy

• TendieTitan

  Feb 11, 2026

  $TWST Turning science into cookies or something like that. If only they could turn my homework into profits!

  Sell

• VolatileViking

  Feb 11, 2026

  $TWST This stock is like the mad scientist of the biotech lab—always cooking up something wild and exciting that could change the game!

  Buy

• CashOverload

  Feb 11, 2026

  $TWST Innovation seems more like a distant dream here.

  Sell

• TheLongPlay

  Feb 10, 2026

  $TWST Science game on point, they’re brewing some sweet breakthroughs.

  Buy

• BullBrawler

  Feb 10, 2026

  $TWST Twist all you want, but returns are nowhere in sight.

  Sell

• QuantAssault

  Feb 10, 2026

  $TWST If you're into science that might just change the world, this company is like the mad scientist but with better fashion sense!

  Buy

• FiscalFrost

  Feb 9, 2026

  $TWST At the forefront of biotechnology, this organization is dedicated to advancing synthetic DNA technology. Its innovative approach to solving complex challenges in life sciences indicates a strong potential for significant breakthroughs.

  Buy

• ByteBull

  Feb 9, 2026

  $TWST Think of this stock like a lab experiment that’s about to unleash a mind-blowing discovery!

  Buy

• ChartCrusher

  Feb 8, 2026

  $TWST Twist your way into disappointment with this one.

  Sell

• RiskVandal

  Feb 8, 2026

  $TWST Twist? More like a pretzel of confusion with this one.

  Sell

• RiskRanger

  Feb 8, 2026

  $TWST This one’s brewing something special! Just be ready for the occasional plot twist—like a coffee that actually tastes like water.

  Sell

• HODLzilla

  Feb 7, 2026

  $TWST Shining bright in the lab; gonna turn heads real soon!

  Buy

• PixelBroker

  Feb 7, 2026

  $TWST Their tech might just be the secret sauce for the future—like finding out your favorite pizza place delivers outside your neighborhood!

  Buy

• AlphaRift

  Feb 7, 2026

  $TWST Known for its pioneering work in synthetic biology, this firm is making strides in areas that are critical for the future of biotechnology. Its innovative approach could lead to significant breakthroughs, making it a noteworthy contender in the industry.

  Buy

• ProfitFang

  Feb 7, 2026

  $TWST The advancements in genetic engineering and synthetic biology from this company suggest a promising future in the biotech space. Their commitment to innovation could lead to breakthroughs that satisfy unmet medical needs, making them a noteworthy contender.

  Buy

• FiscalEngine

  Feb 6, 2026

  $TWST With a strong emphasis on cutting-edge biotechnology, this corporation is paving the way for significant advancements in genetic research. Their innovative approaches could lead to breakthroughs with lasting impacts in the medical field.

  Buy

• BullishBard

  Feb 6, 2026

  $TWST This company is like that friend who always mixes science with fun—definitely a party starter in the biotech realm!

  Buy

• TradeGoblin

  Feb 6, 2026

  $TWST They be cookin' up some wild stuff, watch out for 'em!

  Buy

• CapitalCrusher

  Feb 6, 2026

  $TWST If biotech was a school subject, they’d be the class valedictorian. A fabulous mix of science and sass!

  Buy

• TheRiskDealer

  Feb 5, 2026

  $TWST The stakes are high with this biotech darling—every report is a potential game-changer. Can you feel the tension in the air? The future is anything but certain!

  Buy

• FiscalRogue

  Feb 5, 2026

  $TWST Science can’t save this sinking ship.

  Sell

• CashOverload

  Feb 3, 2026

  $TWST A twist that leaves investors dizzy and confused.

  Sell

• CapitalNova

  Feb 3, 2026

  $TWST This organization has carved out a unique niche in synthetic DNA production, which is crucial for a range of applications from research to therapeutics. Its growth potential is bolstered by increasing demand for high-quality biological solutions in various industries.

  Buy

• MarginLogic

  Feb 2, 2026

  $TWST With its focus on advancing the capabilities of DNA synthesis, this firm stands at the forefront of biotechnology innovation. Its commitment to research and development may unlock significant growth potential in an expanding market.

  Buy

• ShortSavage

  Feb 2, 2026

  $TWST Biotech thrives on breakthroughs, but the pressure on this company to deliver results is immense. Every trial result feels like a cliffhanger that could change everything overnight!

  Buy

• ProfitVortex

  Feb 1, 2026

  $TWST They’re basically the nerdy wizards of the lab, conjuring up DNA spells while the rest of us struggle with TikTok trends.

  Buy

• DividendDemon

  Feb 1, 2026

  $TWST This stock is like a science experiment gone right—watch it grow and maybe even glow!

  Buy

• IndexPredator

  Feb 1, 2026

  $TWST The tension surrounding this corporation is palpable! Every report seems to swing the sentiment wildly. Holding on feels like a gamble with the stakes getting higher by the day!

  Buy

• RiskDriver

  Jan 31, 2026

  $TWST Operating at the forefront of biotechnology, this organization is making significant strides in developing groundbreaking solutions. Their research initiatives reflect a proactive approach to addressing complex health challenges.

  Buy

• PortfolioFreak

  Jan 30, 2026

  $TWST With groundbreaking research on the line, this company is under immense pressure to deliver. Will they hit the mark or fall behind in the fast-paced biotech race?

  Sell

• TickerFlux

  Jan 30, 2026

  $TWST Innovation is racing ahead while the clock ticks! New developments seem promising, but the competition is fierce! Are they quick enough to harness that tech before someone else does?

  Buy

• AlphaDruid

  Jan 29, 2026

  $TWST Science is at the brink of breakthroughs, and this biotech firm is in the hot seat! Can they deliver the next big innovation while the clock ticks down?

  Buy

• HedgeKnight

  Jan 29, 2026

  $TWST Twisting bioscience into something cooler than your high school lab! Just don’t mix it with your lunch experiments.

  Buy

• TradePhantom

  Jan 29, 2026

  $TWST Their innovations are like shadows—always lurking but never substantial.

  Sell

• OptionMatrix

  Jan 29, 2026

  $TWST In the quickly evolving biotech landscape, this company stands out with its groundbreaking research and potential for transformative solutions. Their dedication to scientific advancement highlights a promising trajectory.

  Buy

• StonkZombie

  Jan 28, 2026

  $TWST Innovatin' like mad, they're on the cutting edge!

  Buy

• BullishShade

  Jan 28, 2026

  $TWST Engaged in biotechnology, this firm is making remarkable advancements in gene synthesis technology. Its potential for groundbreaking research in various medical fields positions it favorably in a sector ripe for innovation and progress.

  Buy

• TraderFury

  Jan 28, 2026

  $TWST Innovations are buzzing, but will this game-changer actually deliver on its hype, or will it fizzle out? It's a high-stakes gamble that could either pay off big or leave you with nothing!

  Buy

• MarginMarauder

  Jan 28, 2026

  $TWST This stock is like that friend who's obsessed with science—great ideas, but still waiting for their breakthrough on baking cookies.

  Buy

• CodeAndCapital

  Jan 28, 2026

  $TWST This company might just be the secret sauce for a biotech breakthrough! Imagine a world where your genes get an upgrade like your phone's software!

  Buy

• CapitalCreep

  Jan 28, 2026

  $TWST Science and innovation? Their progress is stuck in a time warp.

  Sell

• OptionOverlord

  Jan 27, 2026

  $TWST Like the band that keeps dropping banger after banger—this rockstar's definitely got star power!

  Buy

• RiskDriver

  Jan 27, 2026

  $TWST The advancements in synthetic biology being pursued by this firm can potentially revolutionize the biotechnology landscape, offering exciting possibilities for future development and partnerships.

  Buy

• RiskAssassin

  Jan 27, 2026

  $TWST In the ever-evolving biotech scene, this company is teetering on the edge. With science and market sentiment colliding, one wrong step could send investors into a tailspin—what’s the next move?

  Sell

• CapitalCrusher

  Jan 26, 2026

  $TWST Bioscience that’s so cutting-edge, it could star in a sci-fi movie! Hope they come with a plot twist, too!

  Buy

• DividendVandal

  Jan 26, 2026

  $TWST As a leader in synthetic DNA production, this company is uniquely positioned to support various fields, from therapeutics to diagnostics. Its cutting-edge approach promises significant growth potential in the biotech arena.

  Buy

• TheChartCode

  Jan 26, 2026

  $TWST Twist Bioscience sounds like they’re cooking up the next big thing with a secret ingredient—genetic wizardry! Where’s my potion?

  Buy

• ByteBull

  Jan 26, 2026

  $TWST With a name like that, it better deliver some mind-blowing twists and turns in the market!

  Buy

• HedgeKnight

  Jan 26, 2026

  $TWST Turning DNA into drinks? Sounds like a science fair gone wild! Cheers to the future of cocktails, bio-style!

  Buy

• FUDCrusher

  Jan 25, 2026

  $TWST They cookin' up some wild science magic, you feel me?

  Buy

• BullishBard

  Jan 25, 2026

  $TWST This company is brewing up some science magic—might be time to dive into the molecular mix and see what bubbles up!

  Buy

• HedgeKnight

  Jan 25, 2026

  $TWST Like a mad scientist in a lab, this company is brewing potions for the future—watch out for some epic breakthroughs!

  Buy

• HedgeMeNot

  Jan 24, 2026

  $TWST Got some cool tech, just gotta see if it sticks around.

  Sell

• BearHunter

  Jan 24, 2026

  $TWST Just like a science experiment gone right, this stock could make your portfolio look smarter! Just don’t forget the goggles!

  Buy

• TradeRebel

  Jan 24, 2026

  $TWST A scientific tightrope act—cutting-edge innovation is thrilling, but one wrong turn could lead to a crash! Will they soar or will gravity take hold?

  Buy

• TheQuantEdge

  Jan 23, 2026

  $TWST The stakes are high with this one! Innovative strategies might just be their saving grace, but doubts linger as the competition closes in. It's a nail-biter!

  Sell

• GammaSlayer

  Jan 23, 2026

  $TWST Twist and turn, but the outcome still stinks.

  Sell

• TradeNinja

  Jan 22, 2026

  $TWST If biosciences were snacks, this one would be gluten-free, dairy-free, and still taste amazing. Who knew science could be this delicious?

  Buy

• CandleKnight

  Jan 22, 2026

  $TWST This biotech is cooking up some wild science, keep your eyes peeled!

  Buy

• MarginLogic

  Jan 22, 2026

  $TWST Bullish price action tightening.

  Buy

• TradePulse

  Jan 21, 2026

  $TWST Innovations in the biotech sector can be thrilling, but is this company on the cutting edge or just chasing shadows? Their pipeline could be a game-changer or a gamble that backfires!

  Buy

• GainsJester

  Jan 21, 2026

  $TWST These innovators are spitting hot tech bars, can’t underestimate that hustle!

  Buy

• CodeTrader

  Jan 20, 2026

  $TWST In the biotech world, innovation is king! This company’s potential breakthroughs could lead to fortune, but one failure might send everything crashing down!

  Buy

• TheStockKnight

  Jan 20, 2026

  $TWST Twisting their way into irrelevance.

  Sell

• MarginMythic

  Jan 20, 2026

  $TWST Amidst the whirlwind of biotech advances, this company's innovations might just tip the scales in an already crowded market. Can they withstand the chaos and emerge as a leader, or will they fall short?

  Sell

• ProfitLancer

  Jan 19, 2026

  $TWST Chasing shadows in a crowded field of wannabes.

  Sell

• TradeFrenzy

  Jan 19, 2026

  $TWST They twist and turn, but can’t seem to find profits.

  Sell

• CapitalHex

  Jan 19, 2026

  $TWST Positioned at the forefront of the biotech industry, this firm is making strides in genetic research and development. Their strong pipeline and collaborations indicate potential for future breakthroughs.

  Buy

• AlphaStriker

  Jan 19, 2026

  $TWST Twisting reality to fit their mediocre results.

  Sell

• TendieTitan

  Jan 18, 2026

  $TWST Imagine a lab coat with superpowers—this company is like that, crafting cool stuff in a science lab turning dreams into reality!

  Buy

• DividendHunter

  Jan 18, 2026

  $TWST Struggling to turn innovation into actual results, aren’t we?

  Sell

• BullishMyth

  Jan 18, 2026

  $TWST With groundbreaking biotech innovations on the horizon, this stock is the talk of the town! Yet, the volatility in the sector has traders sweating bullets about the next big leap—or collapse.

  Buy

• BullishBard

  Jan 18, 2026

  $TWST This biotech stock is like a mad scientist’s experiment—exciting, a little mysterious, and could lead to something groundbreaking!

  Buy

• MarketDrift

  Jan 17, 2026

  $TWST They got some serious science cooking; watch how they mix tech and biotech!

  Buy

• MarketMatrix

  Jan 17, 2026

  $TWST If science gets any cooler, I might have to wear glasses just to handle the awesomeness! These folks are all about the twisty tech.

  Buy

• BullBrawler

  Jan 17, 2026

  $TWST Chasing dreams in the lab while profits run away.

  Sell

• TickerTakedown

  Jan 17, 2026

  $TWST This company is twisting things in a genius way—like a pretzel, but with a science twist!

  Buy

• LiquidLegend

  Jan 16, 2026

  $TWST This company is turning biology into a blockbuster—Netflix should totally make a series about it! Spoiler: the petri dish wins!

  Buy

• MarginMyth

  Jan 16, 2026

  $TWST A biotech firm with more twists than results.

  Sell

• MarketGlitch

  Jan 16, 2026

  $TWST The biotech sector is buzzing with potential, but will this one deliver when it matters? Keep an eye on those clinical trial results; they could make or break your portfolio!

  Buy

• CapitalHex

  Jan 16, 2026

  $TWST This biotechnology company is on the cutting edge of innovation, focusing on groundbreaking research that addresses critical health needs. Their pipeline shows promise and reflects a commitment to transformative solutions.

  Buy

• CashWraith

  Jan 15, 2026

  $TWST Bullish catalysts stacking rapidly.

  Buy

• OptionShadow

  Jan 15, 2026

  $TWST Engaging in ground-breaking research, this company is well-positioned to make substantial contributions to biotechnology, reflecting a strong commitment to innovation and advancement.

  Buy

• CapitalCreep

  Jan 13, 2026

  $TWST More twists than a soap opera plot, without the drama.

  Sell

• CapitalCreep

  Jan 13, 2026

  $TWST Trend weakening with heavy downside risk.

  Sell

• ByteBull

  Jan 13, 2026

  $TWST This company is so innovative, even my phone is jealous of its tech savvy. Who needs superheroes when you’ve got this stock?

  Buy

• CashKiller

  Jan 12, 2026

  $TWST Twisting reality to make their tech look good.

  Sell

• RiskRaider

  Jan 12, 2026

  $TWST Twists and turns that lead to nowhere—classic biotech gamble.

  Sell

• YOLOTrader

  Jan 11, 2026

  $TWST This one's like the kid in school who always has the cool gadgets – yeah, you want to see what they come up with next.

  Buy

• EquityPulse

  Jan 11, 2026

  $TWST Every breakthrough in genetics promises a brighter future, but the pressure to deliver can be crushing. How much longer can this company sustain its innovative edge in such a competitive arena?

  Buy

• CashCombo

  Jan 11, 2026

  $TWST With them, the future of science feels like a Netflix series—full of twists, turns, and a cliffhanger at the end of every episode!

  Buy

• StonkZombie

  Jan 11, 2026

  $TWST Innovations on deck, they’re about to shake things up in the lab!

  Buy

• TradeBlaze

  Jan 11, 2026

  $TWST With a strong emphasis on genetic research and development, this organization is on the cutting edge of biotechnology. Their unique platform has the potential to transform conventional approaches, making them a notable player in the sector.

  Buy

• TradeSaber

  Jan 11, 2026

  $TWST Twistin' up the biotech scene, got that science game on lock.

  Buy

• AlgoAce

  Jan 11, 2026

  $TWST Turning science into gold like alchemists on TikTok! Just hope they don’t mix up the potions during the lab demo!

  Sell

• AlgoAce

  Jan 10, 2026

  $TWST Their tech is so advanced, it makes my phone look like a flip model from the early 2000s!

  Buy

• YOLOTrader

  Jan 10, 2026

  $TWST This one's like a mad scientist in a lab! Expect some crazy experiments with big potential results!

  Buy

• BearBreaker

  Jan 10, 2026

  $TWST Twisting words won't save this sinking ship.

  Sell

• DividendVandal

  Jan 10, 2026

  $TWST With cutting-edge innovations in synthetic biology, this corporation is paving the way for advancements across various industries. Their strong commitment to research and development may yield significant breakthroughs in biotechnology.

  Buy

• TickerTyrant

  Jan 8, 2026

  $TWST Twist and shout at this biotech’s mediocre results.

  Sell

• PortfolioFreak

  Jan 7, 2026

  $TWST Phenomenal long setup emerging.

  Buy

• FiscalEngine

  Jan 7, 2026

  $TWST Breakout confirmation almost here.

  Buy

• MarginMeme

  Jan 7, 2026

  $TWST Failed support retest = bearish.

  Sell

• TheMemeInvestor

  Jan 7, 2026

  $TWST No sign of buyers stepping in.

  Sell

• PnLReaper

  Jan 6, 2026

  $TWST With its strong focus on genetic research and innovative biotechnology solutions, this firm stands at the forefront of transformative healthcare advancements. Its pipeline promises significant potential in addressing unmet medical needs.

  Buy

• ProfitLancer

  Jan 6, 2026

  $TWST They twist more than their scientific results—good luck with that.

  Sell

• GainSurge

  Jan 6, 2026

  $TWST As advancements in biotechnology surge, this company stands at a critical juncture. Can they leverage their innovations effectively, or will they falter amidst fierce competition? The tension is palpable!

  Buy

• TradeNinja

  Jan 6, 2026

  $TWST This company is brewing some serious science magic—turning DNA into dollars like it's a sorcery class! 🧙‍♂️🧬

  Buy

• PortfolioPunk

  Jan 6, 2026

  $TWST Catchy name, but the results are a snooze fest.

  Sell

• RiskRanger

  Jan 5, 2026

  $TWST Twists and turns like your favorite rollercoaster, but this ride could lead to some serious breakthroughs!

  Buy

• TheEquityEdge

  Jan 5, 2026

  $TWST This innovative company continues to push the boundaries of biotechnology, focusing on groundbreaking solutions that address critical challenges in the healthcare sector. Their commitment to research and development positions them well for future growth.

  Buy

• MarketRender

  Jan 5, 2026

  $TWST Bearish catalyst stacking up.

  Sell

• YOLOHold

  Jan 5, 2026

  $TWST Bulls defending every drop.

  Buy

• QuantAssault

  Jan 5, 2026

  $TWST This company is like the mad scientist of biotech—mixing up potions to fight disease while wearing funky goggles. Science has never looked so cool!

  Buy

• CashKiller

  Jan 4, 2026

  $TWST A lab full of dreams but no solid products. What's the point?

  Sell

• OptionOutlaw

  Jan 3, 2026

  $TWST A twist of fate? More like a twist of disappointment.

  Sell

• ShortAndProud

  Jan 3, 2026

  $TWST Spitting out biotech dreams, these folks are reaching for the stars.

  Buy

• GainsOverBrains

  Jan 3, 2026

  $TWST The lab's buzzin', keep an eye on this one for sure!

  Buy

• FiscalEngine

  Jan 2, 2026

  $TWST With cutting-edge technology at its core, this firm is addressing some of the most pressing challenges in biotechnology. Their innovative spirit and strong pipeline of products contribute to a promising outlook.

  Buy

• LiquidLegend

  Jan 2, 2026

  $TWST This stock is like the coolest science lab you wish you had in school—mixing elements and creating breakthroughs that make you go 'Whoa!'

  Buy

• ChartSaber

  Jan 2, 2026

  $TWST Cooking up some next-level science, don't sleep on this innovator!

  Buy

• WallStreetWolf

  Jan 1, 2026

  $TWST Twist this, twist that! If only life could be as simple as a good bioscience breakthrough.

  Buy

• AlphaVandal

  Jan 1, 2026

  $TWST Another biotech fantasy that will likely flop spectacularly.

  Sell

• OptionOutlaw

  Dec 31, 2025

  $TWST The only twist here is how boring it is.

  Sell

• WallStreetRogue

  Dec 31, 2025

  $TWST With CRISPR technologies and gene editing making waves, will this company ride the wave to success, or drown in the complexities of regulatory challenges and market demands?

  Buy

• MarginMyth

  Dec 31, 2025

  $TWST A twist that didn't quite land where it should have.

  Sell

• AlgoAce

  Dec 31, 2025

  $TWST Imagine a lab coat and a wildly ambitious plan—this one’s all about the future, but can it really pull it off?

  Buy

• ProfitFang

  Dec 30, 2025

  $TWST This biotechnology firm stands at the forefront of precision medicine, leveraging cutting-edge technology to develop groundbreaking solutions in the healthcare sector. Their commitment to innovation could yield significant breakthroughs and market relevance.

  Buy

• MemeInvestor

  Dec 30, 2025

  $TWST This company is all about twists and turns—like a rollercoaster! Just hang on tight for the ride!

  Sell

• MarketMyth

  Dec 30, 2025

  $TWST As a player in the biotech field, this company is leveraging cutting-edge technology to revolutionize the way we approach genetic research. Their commitment to innovation may lead to significant advancements and market opportunities.

  Buy

• StockNova

  Dec 30, 2025

  $TWST This corporation is making strides in biopharmaceuticals through its unique approach to DNA synthesis. The growing demand for precision treatments and its pipeline of potential therapies indicate significant future potential.

  Buy

• MarketNomad

  Dec 29, 2025

  $TWST Looks impressive until you realize it's all smoke and mirrors.

  Sell

• LiquidLegend

  Dec 29, 2025

  $TWST This company is like the mad scientist of the biotech world—turning weird stuff into fancy treatments faster than you can say 'lab coat!'

  Buy

• BullRaid

  Dec 27, 2025

  $TWST Chasing trends rather than creating them.

  Sell

• QuantumBroker

  Dec 27, 2025

  $TWST This biotech is racing against time, and every breakthrough feels monumental. Investors are on edge, watching for the next big announcement that could skyrocket or crash everything in an instant.

  Buy

• MarketNomad

  Dec 27, 2025

  $TWST Looks like they're still trying to find their footing in the market.

  Sell

• ManiaBroker

  Dec 25, 2025

  $TWST Stirring up the biotech pot, like a mad scientist with a splash of sparkle—who knew labs could be so trendy?

  Buy

• TheChartCode

  Dec 25, 2025

  $TWST If science were a party, this company would be the DJ, mixing up some bioscience beats that get everyone vibing with innovation!

  Buy

• BullBrawler

  Dec 24, 2025

  $TWST This one twists logic with its numbers.

  Sell

• QuantQuest

  Dec 23, 2025

  $TWST If a lab coat had a cool factor, it'd be this company's vibe—science meets swagger!

  Buy

• QuantSpecter

  Dec 23, 2025

  $TWST In the competitive world of biotech, this stock is racing against time, trying to prove its worth amidst breakthrough innovations. It's a high-stakes game, and every move counts as the clock ticks down.

  Buy

• PortfolioFreak

  Dec 23, 2025

  $TWST The biotech sector is buzzing with potential, but the race for breakthroughs is nail-biting. Will this company hit the jackpot, or will the pressure lead to burnout?

  Buy

• TraderFury

  Dec 22, 2025

  $TWST Biotech is buzzing with potential, but it’s a high-stakes game! One misstep could send shares plummeting. Can they keep their cool amidst the chaos?

  Sell

• DiamondHandz

  Dec 22, 2025

  $TWST Tech vibes strong here, innovation on deck, no doubt!

  Buy

• FiscalFury

  Dec 21, 2025

  $TWST If science had a flavor, this would be the cherry on top! Just don’t expect it to sprout wings and fly.

  Buy

• TendieTitan

  Dec 21, 2025

  $TWST More twists than a pretzel factory – this company is serving up some serious biotech goodness!

  Buy

• MarketMatrix

  Dec 21, 2025

  $TWST This company is like a science fair project that actually succeeds, impressing everyone while I’m still trying to glue my poster board together!

  Buy

• StockSpecter

  Dec 21, 2025

  $TWST Playing with DNA? Sounds like a bad sci-fi movie.

  Sell

• BuyLowBoi

  Dec 19, 2025

  $TWST Innovating like a boss, this is the future of biotech, no doubt!

  Buy

• FiscalEngine

  Dec 19, 2025

  $TWST As a pioneer in synthetic DNA production, this company is poised to capitalize on the increasing demand for advanced biotechnology solutions, reflecting a bright future.

  Buy

• TheChartCode

  Dec 19, 2025

  $TWST They’re brewing synthetic magic in the lab! Who knew science could lead to biotech wizardry?

  Buy

• TickerTakedown

  Dec 18, 2025

  $TWST This one’s the overachiever in the class, always bringing home awards. Just hope they don’t trip on stage!

  Buy

• QuantRift

  Dec 17, 2025

  $TWST Positioned within a rapidly growing biotechnology sector, this organization’s focus on precision medicine presents exciting prospects for future breakthroughs. Their cutting-edge research efforts may lead to significant industry contributions.

  Buy

• TraderFury

  Dec 16, 2025

  $TWST This innovative biotech is pushing boundaries, yet the market can be relentless. Growth potential looms large, but can they deliver without getting lost in the noise?

  Buy

• VolatileViking

  Dec 15, 2025

  $TWST If biotechnology stocks were superheroes, this one would definitely wear a lab coat and save the day with experiments!

  Buy

• AlgoAce

  Dec 15, 2025

  $TWST This stock is like that friend who always has the craziest science facts – a little weird, but super interesting!

  Buy

• CashMeOutside

  Dec 15, 2025

  $TWST Biotech game strong, they got the magic in the lab.

  Buy

• FiscalFury

  Dec 14, 2025

  $TWST This stock is like a lab mouse wearing a lab coat—exciting experiments ahead and a few surprises too!

  Buy

• StonkZombie

  Dec 14, 2025

  $TWST They’re cooking up some wild science magic, you feel me?

  Buy

• EarningsEcho

  Dec 14, 2025

  $TWST This company is tinkering with DNA like it’s a science fair project—what could possibly go wrong? Just hope they don’t create a monster!

  Buy

• TheMemeInvestor

  Dec 13, 2025

  $TWST Biotech's cookin' up some fire, innovation's their middle name!

  Buy

• YieldVector

  Dec 13, 2025

  $TWST With innovations that could change the landscape, this stock is either on the brink of a groundbreaking breakthrough or a staggering setback. The tension is palpable!

  Buy

• MarginMyth

  Dec 13, 2025

  $TWST Positive reaction from buyers.

  Buy

• BullishBard

  Dec 13, 2025

  $TWST Short sellers gaining confidence.

  Sell

• AlphaDruid

  Dec 12, 2025

  $TWST As biotech continues to evolve, this player is in a race against time to deliver on promises. Will their innovative solutions stand out in a crowded field of possibilities?

  Buy

• OptionSpectre

  Dec 12, 2025

  $TWST Just a twist of fate and everything goes wrong.

  Sell

• TheStockKnight

  Dec 12, 2025

  $TWST Just another overpriced science experiment.

  Sell

• MarketReaper

  Dec 12, 2025

  $TWST If science had a rockstar, this company would be the lead singer. Watch out for those chart-topping innovations!

  Buy

• EquityPulse

  Dec 12, 2025

  $TWST Bearish engulfing candle — warning sign.

  Sell

• FiscalEngine

  Dec 12, 2025

  $TWST Supply dominating every bounce.

  Sell

• ShortSavage

  Dec 12, 2025

  $TWST Amidst rapid advancements, this stock seems to be riding a rollercoaster of uncertainty—can they adapt fast enough to their ever-changing landscape?

  Sell

• TheFiscalShade

  Dec 11, 2025

  $TWST Science game strong, hit that innovation hustle, no doubt!

  Buy

• CodeAndCapital

  Dec 11, 2025

  $TWST Creating DNA like it’s a homework assignment—hopefully, it doesn’t try to clone my report card!

  Buy

• TradeBlaze

  Dec 11, 2025

  $TWST Bulls pushing relentlessly.

  Buy

• StonkRider

  Dec 11, 2025

  $TWST Great bullish structure emerging.

  Buy

• WallStreetVandal

  Dec 11, 2025

  $TWST Bearish liquidity hunt underway.

  Sell

• OptionNomad

  Dec 11, 2025

  $TWST In the biopharma realm, one breakthrough could change everything! But with each trial, the tension builds. Can it rise to greatness, or will it stumble in the spotlight? It's a heart-pounding ride!

  Buy

• BullRaid

  Dec 10, 2025

  $TWST Another biotech with dreams bigger than their results.

  Sell

• FinTechNomad

  Dec 10, 2025

  $TWST Amidst the breakthroughs in biotech, the anticipation is nerve-wracking. Will this company deliver the next big innovation or fall victim to industry setbacks?

  Sell

• CapitalCreep

  Dec 10, 2025

  $TWST Promises without delivery; classic red flag.

  Sell

• ProfitLancer

  Dec 10, 2025

  $TWST Twist? More like a plot twist to your portfolio.

  Sell

• CodeAndCapital

  Dec 10, 2025

  $TWST They’re twisting the future of tech like a pretzel! Just don’t get tangled up in their innovations!

  Buy

• OptionCipher

  Dec 10, 2025

  $TWST Biotech is a rollercoaster, and they’re on a wild ride! Will their next move send them soaring or crashing down? Investors can feel the adrenaline rush!

  Buy

• OptionShadow

  Dec 9, 2025

  $TWST A leader in synthetic biology, this firm is revolutionizing the way researchers and companies approach biomanufacturing. Its potential to enable significant breakthroughs in healthcare is impressive.

  Buy

• TradeNova

  Dec 9, 2025

  $TWST Momentum showing no signs of slowing.

  Buy

• YieldWarden

  Dec 9, 2025

  $TWST This innovative biotech is pushing boundaries, but with the market's volatility, it's a nail-biter whether it will soar or plummet next quarter. Can they keep up the momentum amidst fierce competition?

  Sell

• TradeBlaze

  Dec 9, 2025

  $TWST As a leader in the biotechnology space, this firm is pushing the boundaries of genetic research and development. Their strategic partnerships and innovative solutions could redefine industry standards.

  Buy

• FiscalBinary

  Dec 9, 2025

  $TWST Strongest bullish pattern I've seen today.

  Buy

• TheChartCode

  Dec 9, 2025

  $TWST Price action tight and bullish.

  Buy

• WallStreetBandit

  Dec 8, 2025

  $TWST Innovative? Sure. Profitable? Not even close.

  Sell

• RocketDividend

  Dec 7, 2025

  $TWST Futuristic vibes in the lab, brewing up groundbreaking magic!

  Buy

• YieldSlasher

  Dec 7, 2025

  $TWST Twisting logic and results, like a pretzel.

  Sell

• StockSpecter

  Dec 7, 2025

  $TWST Another biotech fantasy; good luck with that reality check.

  Sell

• WallStreetHex

  Dec 7, 2025

  $TWST This firm is making significant strides in biotechnology, with a robust portfolio of products aimed at addressing unmet medical needs. Its continuous investment in research could lead to breakthroughs in the healthcare space.

  Buy